Current and future trend of chemotherapy for ovarian cancer
Fujiwara, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(2): 164-165
2015
ISSN/ISBN: 0385-0684 PMID: 25834912 Document Number: 685670
Document emailed within 1 workday
Related Documents
Ozols, R.F.; Vermorken, J.B. 1997: Chemotherapy of advanced ovarian cancer: current status and future directions Seminars in Oncology 24(1 Suppl 2: S2Li, L.; Yang, Z.J.; Wang, Q. 2017: Current status and future of epithelial ovarian cancer markers Zhonghua Fu Chan Ke Za Zhi 52(1): 4-7
Tomioka, H.; Tada, A. 2010: Can we have adequate chemotherapy regimens for tuberculosis in the future? Current status and future prospects for development of new antituberculosis drugs Kekkaku: 85(2): 113-123
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Ozols, R.F.; Young, R.C. 1991: Chemotherapy of ovarian cancer Seminars in Oncology 18(3): 222-232
Friedman, M.A. 1983: Hepatic intraarterial chemotherapy--current status and future prospects--"If you have a short sword, take a step forward" Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(5): 1209-1224
Djordjevic, B.; Stojanovic, S.; Conic, I.; Jankovic-Velickovic, L.; Vukomanovic, P.; Zivadinovic, R.; Vukadinovic, M. 2012: Current approach to epithelial ovarian cancer based on the concept of cancer stem cells Journal of BUON: Official Journal of the Balkan Union of Oncology 17(4): 627-636
Awada, A.; Klastersky, J. 2004: Ovarian cancer: state of the art and future directions European Journal of Gynaecological Oncology 25(6): 673-676
Nishimura, H.; Imamura, K.; Chang, C. 1996: Chemotherapy for recurrent ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1124-1128
Ochiai, K. 1994: Tumors. a. Chemotherapy of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 46(8): 821-831
Wang, J.; Li, A.J.; Karlan, B.Y. 2002: Chemotherapy in epithelial ovarian cancer Current Women's Health Reports 2(1): 20-26
Paulus, A.; Gennigens, C.; Fillet, G.; Loly, C.; Sautois, B. 2007: Chemotherapy of ovarian cancer: state of the art Revue Medicale de Liege 62(9): 539-547
Anselmo-Murphy, A.M. 2009: Challenges of IP chemotherapy for ovarian cancer Oncology 23(11 Suppl Nurse Ed): 21-22
Camci, C.; Balat, O. 2002: Neoadjuvant chemotherapy in ovarian cancer European Journal of Gynaecological Oncology 23(5): 437-441
Onda, T. 2012: Neoadjuvant chemotherapy for ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(6): 882-886
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Shelling, A.N.; Cooke, I.E.; Le Meuth, V.G.; Ganesan, T.S. 1996: Epithelial ovarian cancer: future prospects for treatment New Zealand Medical Journal 109(1020): 131-132
Katsaros, D.; Fracchioli, S.; Arese, P.; Enria, R.; Cassinelli, P.; Mingrone, K.; Piccinno, R.; Rigault de la Longrais, I.A.; Massobrio, M. 1999: Chemoresistance in ovarian cancer. State of the art and future prospects Minerva Ginecologica 51(12): 483-499
Gazárek, F.; Kudela, M.; Talas, M.; Fingerová, H. 1976: Possibilities of a directed chemotherapy in ovarian cancer Ceskoslovenska Gynekologie 41(10): 719-721